Wake Up Wall Street (SPY) (QQQ): Is this a double top?
Premium|Take advantage of 50% OFF on your first month.
Start your subscription and get access to all our original articles.
You have reached your limit of 5 free articles for this month.
Get Premium without limits for only $9.99 for the first month
Access all our articles, insights, and analysts.
UNLOCK OFFERHere is what you need to know on Thursday, October 21:
The Dow just about managed to set a new all-time intraday high on Wednesday before coming down slightly. Now this sets up an intriguing potential double top. Stocks are set to open lower on Thursday, so technical analysts will be all over this one. The latest rally has not been the broadest with the number of stocks making new highs falling and also the number of stocks above the 200-day moving average.
The dollar is calm as yields are steady and stocks are strong. The dollar is at 1.1644 now versus the euro. Bitcoin is all the rage after the launch of the first futures ETF on Tuesday. More similar ETFs are soon to come. Bitcoin tops out at new all-time highs but is back to $65,000 now. Gold is at $1,783.
European markets are mostly flat: Eurostoxx and Dax are flat, FTSE is -0.3%.
US futures are lower: S&P, Nasdaq and Dow are all down -0.15%.
Wall Street (SPY) (QQQ) news
AT&T (T) beats estimates, stock up over 1% premarket.
Tesla (TSLA) beat last night on EPS, revenue and margins.
IBM misses on revenue and stock drops over 4%.
American Airlines (AAL) reports a surprise profit. EPS and revenue beats.
Dow (DOW) beats on revenue and EPS, up 1% premarket.
Quest Diagnostics (DGX): $3.96 EPS v $2.88 estimate, up 3% premarket.
Paypal (PYPL) reportedly bidding for Pinterest (PINS), see more.
Crocs (CROX) up over 10% as earnings again smash it. Sales up nearly 70%.
Southwest Airlines (LUV) beats on EPS and revenue.
Unilever (UL) up 1% on resutls.
Pfizer (PFE) BioNTech (BNTX): research from Israel shows strong protection against Delta variant.
Earnings, upgrades, downgrades and premarket movers
Source: Benzinga Pro
Economic releases
Here is what you need to know on Thursday, October 21:
The Dow just about managed to set a new all-time intraday high on Wednesday before coming down slightly. Now this sets up an intriguing potential double top. Stocks are set to open lower on Thursday, so technical analysts will be all over this one. The latest rally has not been the broadest with the number of stocks making new highs falling and also the number of stocks above the 200-day moving average.
The dollar is calm as yields are steady and stocks are strong. The dollar is at 1.1644 now versus the euro. Bitcoin is all the rage after the launch of the first futures ETF on Tuesday. More similar ETFs are soon to come. Bitcoin tops out at new all-time highs but is back to $65,000 now. Gold is at $1,783.
European markets are mostly flat: Eurostoxx and Dax are flat, FTSE is -0.3%.
US futures are lower: S&P, Nasdaq and Dow are all down -0.15%.
Wall Street (SPY) (QQQ) news
AT&T (T) beats estimates, stock up over 1% premarket.
Tesla (TSLA) beat last night on EPS, revenue and margins.
IBM misses on revenue and stock drops over 4%.
American Airlines (AAL) reports a surprise profit. EPS and revenue beats.
Dow (DOW) beats on revenue and EPS, up 1% premarket.
Quest Diagnostics (DGX): $3.96 EPS v $2.88 estimate, up 3% premarket.
Paypal (PYPL) reportedly bidding for Pinterest (PINS), see more.
Crocs (CROX) up over 10% as earnings again smash it. Sales up nearly 70%.
Southwest Airlines (LUV) beats on EPS and revenue.
Unilever (UL) up 1% on resutls.
Pfizer (PFE) BioNTech (BNTX): research from Israel shows strong protection against Delta variant.
Earnings, upgrades, downgrades and premarket movers
Source: Benzinga Pro
Economic releases
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.